No Data
Hong Kong stock concept tracking | Domestic medical insurance negotiation is expected to yield results this week. Innovative drug industry leaders are receiving attention (Concept stocks attached).
After the "Implementation Plan to Support the Development of Innovative Drugs Throughout the Entire Chain" in this round of medical insurance negotiations, the first national medical insurance negotiations attracted much attention to the attitude towards innovative drugs.
Pacific Securities initiates coverage on Akeso (09926) with a "buy" rating, expecting the company to achieve profitability in 2025.
Jinwu Financial News | The pacific securities released a research report stating that akeso (09926) announced the HARMONi-2 landmark study results at the World Lung Cancer Conference (WCLC), showing that in the first-line treatment of PD-L1 positive advanced NSCLC patients, anlotinib achieved the longest median PFS to date compared to pembrolizumab. The median PFS in the anlotinib group reached 11.14 months, and the data is still immature; the median PFS in the pembrolizumab group was 5.8 months and the data is mature. The PFS K-M curves of the two groups separated very quickly, with a particularly significant extent, and the PFS HR was 0.51.
While Institutions Invested in Akeso, Inc. (HKG:9926) Benefited From Last Week's 5.0% Gain, Individual Investors Stood to Gain the Most
Express News | Akeso's Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma Accepted by Nmpa
China Merchants Securities: Establishment of prepayment policy for medical insurance funds, releasing incremental signals at the bottom of the pharmaceutical sector.
It is reported that standardized prepayment process management, with the scale of regional prepayment in line with the approved standards for about one month, the prepayment system effectively alleviates the financial pressure of medical institutions, empowering the medical and pharmaceutical industry.
Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks
No Data
No Data
MayFlower : It was predictable..
Midnite52 : yep